Health Condition 1: K039- Disease of hard tissues of teeth,unspecified
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Males and Females, between 18-65 years of age; Informed Consent Form signed and availability for the duration of the study; Good general health (absence of any condition that, in the opinion of the Principal Investigator, might constitute a risk to the subject while participating in the study. Examples include heart problems, valve/hip replacements, etc.) Willingness to provide information related to their medical history Minimum of 10 uncrowned permanent natural teeth (excluding wisdom teeth)
Exclusion criteria
Exclusion criteria: Hepatitis B or C, HIV infection, oral herpes (cold sore), sinusitis, etc., based on self-reported medical history; Premedication required for dental procedures; Current or history of infectious disease (i.e. Current contagious illness, upper respiratory infections) based on self-reported medical history; Oral pathology, chronic disease, or a history of allergy to oral care products, teeth whitening products, hydrogen peroxide, personal care consumer products, or their ingredients; Wearing removable retainers, dentures or with fixed orthodontic appliances; Obvious signs of periodontal disease, rampant caries, or any condition that the dental examiner considers exclusionary from the study; Using anticonvulsants, antihistamines, antidepressants, sedatives, tranquilizers, anti-inflammatory medication or daily analgesics within one month prior to the start of the study or scheduled to start such intake during the course of the study; Participating in any other clinical study that might interfere with the main study outcome; Pregnant or breastfeeding; Ongoing use of medications known to affect the gum tissues (i.e. calcium channel blockers, phenytoin, cyclosporine); Use of antibiotics any time during or three months prior to entry into the study. Use of therapeutic oral care products within 1 month prior to entry into the study. Abnormal salivary function including medication induced dry mouth Five (5) or more decayed untreated dental sites at screening Active periodontal disease (ie purulent exudate or tooth mobility), or having received periodontal treatment (ex: SRP- scaling and root planing) 6 months before entering study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| General health status Oral health status Oral hygiene practices Microbiome characterization Timepoint: Single time point (baseline) | — |
Secondary
| Measure | Time frame |
|---|---|
| NILTimepoint: NIL | — |
Countries
India
Contacts
Colgate-Palmolive India Limited